SCHEMBL4885707

SCHEMBL4885707

COCCC(=O)NC(C)c1ccc(Nc2ncc3cc(-c4cnccc4C)ccc3n2)cc1

nearest known ligand 0.83

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ BRAF P15056 20/20 0.83
▸ RAF1 P04049 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3041914 0.91 BRAF (1.00) BRAFRAF1
SCHEMBL3029338 0.91 BRAF (1.00) BRAFRAF1
SCHEMBL3035097 0.91 BRAF (1.00) BRAFRAF1
SCHEMBL3039611 0.79 BRAF (1.00) BRAFRAF1
SCHEMBL3032995 0.77 BRAF (1.00) BRAF
SCHEMBL3031572 0.77 BRAF (1.00) BRAF
SCHEMBL3031569 0.77 BRAF (1.00) BRAF
SCHEMBL3040951 0.76 BRAF (1.00) BRAFRAF1
SCHEMBL3033956 0.72 BRAF (1.00) BRAFRAF1
SCHEMBL4735381 0.72 BRAF (0.78) BRAFRAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008068507-A2 2 -PHENYLAMINO, 6- (PYRID-3-YL) QUINAZOLINE DERIVATIVES AS RAF-PROTEIN KINASE INHIBITORS IN CANCER TREATMENT ASTRAZENECA AB (SE) 2008-06-12 — — WO claimed
Send feedback